TMC Life Sciences Berhad reported unaudited consolidated earnings results for the quarter and six months ended November 30, 2017. For the quarter, the company reported revenue of MYR 41,728,000 against MYR 36,202,000 a year ago. Profit from operations was MYR 9,423,000 against MYR 6,587,000 a year ago. Profit before taxation was MYR 8,324,000 against MYR 6,105,000 a year ago. Profit attributable to owners of the parent was MYR 6,329,000 or 0.34 sen per diluted share against MYR 4,439,000 or 0.23 sen per diluted share a year ago. Higher revenue was mainly due to higher patient load, higher intensity cases handled, additional consultants recruited and continuing marketing activities. Higher profit before tax margin of 20% compared to quarter ended 30 November 2016 of 17% was mainly due to resource optimisation during the quarter. For the six months, the company reported net cash flows from operating activities were MYR 9,533,000 against MYR 5,769,000 a year ago. Acquisition of property plant and equipment was MYR 5,949,000 against MYR 6,176,000 a year ago.